INTERFERON BETA-1B

INTERFERON BETA-1B was reported 19077 times

INTERFERON BETA-1B is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL KNEE DISLOCATION 9 0.2250
1 ANTI-INTERFERON ANTIBODY POSITIVE 21 0.2121
2 INJECTION SITE CALCIFICATION 15 0.1200
3 INJECTION SITE ULCER 83 0.0880
4 INJECTION SITE NECROSIS 134 0.0657
5 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 8 0.0645
6 NEUTRALISING ANTIBODIES 8 0.0635
7 INJECTION SITE CELLULITIS 108 0.0581
8 AUTOMATIC BLADDER 8 0.0580
9 INJECTION SITE SCAR 145 0.0508
10 NEUTRALISING ANTIBODIES POSITIVE 20 0.0480
11 INJECTION SITE INFECTION 148 0.0450
12 INJECTION SITE ATROPHY 66 0.0401
13 INJECTION SITE EROSION 14 0.0398
14 NEEDLE FATIGUE 18 0.0394
15 PROGRESSIVE MULTIPLE SCLEROSIS 41 0.0355
16 INJECTION SITE ABSCESS 78 0.0313
17 INJECTION SITE NERVE DAMAGE 7 0.0293
18 INJECTION SITE SCAB 28 0.0290
19 NEUROMYELITIS OPTICA 9 0.0269
20 RELAPSING MULTIPLE SCLEROSIS 8 0.0265
21 HEMIANAESTHESIA 20 0.0251
22 INJECTION SITE HYPERTROPHY 8 0.0245
23 MULTIPLE SCLEROSIS 1166 0.0244
24 RELAPSING-REMITTING MULTIPLE SCLEROSIS 21 0.0243
25 POSTOPERATIVE INFECTION 11 0.0232
26 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 11 0.0227
27 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 39 0.0207
28 DECREASED VIBRATORY SENSE 7 0.0206
29 CONGENITAL MUSCULOSKELETAL ANOMALY 9 0.0204
30 GAIT SPASTIC 7 0.0204
31 MULTIPLE SCLEROSIS RELAPSE 1346 0.0196
32 LOWER EXTREMITY MASS 12 0.0194
33 LIPOATROPHY 17 0.0179
34 INFLUENZA LIKE ILLNESS 1404 0.0170
35 BASEDOW'S DISEASE 8 0.0170
36 JC VIRUS TEST POSITIVE 14 0.0166
37 BAND SENSATION 21 0.0165
38 TRAUMATIC FRACTURE 12 0.0163
39 MYOPATHY TOXIC 10 0.0162
40 INJECTION SITE INDURATION 185 0.0143
41 INJECTION SITE INFLAMMATION 69 0.0138
42 AGRAPHIA 8 0.0134
43 FAT NECROSIS 8 0.0132
44 INJECTION SITE MASS 481 0.0130
45 INJECTION SITE REACTION 842 0.0122
46 MYELITIS TRANSVERSE 17 0.0121
47 DECREASED INTEREST 71 0.0120
48 INJECTION SITE EXFOLIATION 8 0.0120
49 OPTIC NEURITIS 109 0.0120
50 EXTENSOR PLANTAR RESPONSE 11 0.0119
51 PERONEAL NERVE PALSY 67 0.0118
52 QUADRIPLEGIA 24 0.0116
53 JOINT SPRAIN 12 0.0115
54 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 38 0.0115
55 ABASIA 279 0.0113
56 INJECTION SITE DRYNESS 10 0.0110
57 SOFT TISSUE INJURY 8 0.0106
58 SENSATION OF HEAVINESS 40 0.0103
59 INJECTION SITE HAEMATOMA 149 0.0103
60 JC POLYOMAVIRUS TEST POSITIVE 12 0.0102
61 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 14 0.0096
62 LACK OF INJECTION SITE ROTATION 16 0.0091
63 DIPLEGIA 18 0.0091
64 THYROID NEOPLASM 25 0.0091
65 APHAGIA 43 0.0089
66 SKIN NECROSIS 46 0.0089
67 EXPIRED DEVICE USED 29 0.0087
68 RAYNAUD'S PHENOMENON 8 0.0085
69 INJECTION SITE RASH 260 0.0085
70 PARAPARESIS 15 0.0084
71 MUSCLE SPASTICITY 103 0.0084
72 PANNICULITIS 20 0.0083
73 INJECTION SITE DISCOLOURATION 101 0.0081
74 HAEMANGIOMA OF LIVER 8 0.0079
75 INJECTION SITE ERYTHEMA 978 0.0079
76 CENTRAL NERVOUS SYSTEM LESION 108 0.0079
77 ORAL INTAKE REDUCED 19 0.0079
78 DEPRESSION SUICIDAL 27 0.0078
79 INCISION SITE INFECTION 7 0.0077
80 TRIGEMINAL NEURALGIA 31 0.0077
81 SEIZURE LIKE PHENOMENA 13 0.0077
82 JC VIRUS INFECTION 12 0.0075
83 THERAPEUTIC PRODUCT INEFFECTIVE 29 0.0075
84 ABDOMINAL MASS 20 0.0075
85 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 9 0.0072
86 OPEN WOUND 8 0.0071
87 DIFFICULTY IN WALKING 24 0.0070
88 DECUBITUS ULCER 56 0.0069
89 BLADDER DYSFUNCTION 7 0.0068
90 COORDINATION ABNORMAL 94 0.0067
91 ANTIBODY TEST POSITIVE 11 0.0066
92 DEVICE INEFFECTIVE 7 0.0065
93 BLADDER SPASM 12 0.0064
94 FAECAL INCONTINENCE 30 0.0062
95 NEUROGENIC BLADDER 13 0.0062
96 MOTOR DYSFUNCTION 62 0.0061
97 MONOPARESIS 11 0.0061
98 HYPOAESTHESIA FACIAL 9 0.0060
99 MAGNETIC RESONANCE IMAGING ABNORMAL 7 0.0059
100 INFECTED SKIN ULCER 11 0.0058
101 BREAST DISCHARGE 10 0.0057
102 DEMYELINATION 23 0.0056
103 INJECTION SITE BRUISING 439 0.0055
104 DEVICE POWER SOURCE ISSUE 16 0.0055
105 NOSOCOMIAL INFECTION 12 0.0054
106 HEPATOCELLULAR DAMAGE 12 0.0053
107 THYROID FUNCTION TEST ABNORMAL 22 0.0053
108 BLADDER DISORDER 52 0.0052
109 HYPOREFLEXIA 10 0.0052
110 PARAPLEGIA 15 0.0052
111 MYELITIS 8 0.0052
112 SPINAL CORD INJURY 9 0.0052
113 FACIAL PALSY 11 0.0051
114 CHILLS 597 0.0051
115 BALANCE DISORDER 433 0.0050
116 SPINAL CORD DISORDER 8 0.0049
117 NECROSIS 27 0.0048
118 HYPERTONIC BLADDER 14 0.0048
119 SKIN INDURATION 10 0.0048
120 LIVEDO RETICULARIS 10 0.0048
121 WALKING AID USER 31 0.0047
122 MOBILITY DECREASED 328 0.0046
123 INJECTION SITE PARAESTHESIA 7 0.0046
124 URINARY INCONTINENCE 135 0.0046
125 PARALYSIS 65 0.0045
126 HYPOAESTHESIA 673 0.0045
127 HEMIPARESIS 75 0.0044
128 HEPATIC ENZYME ABNORMAL 22 0.0044
129 INJECTION SITE URTICARIA 107 0.0044
130 CONVULSION 249 0.0043
131 EXCORIATION 11 0.0043
132 COLONIC POLYP 7 0.0042
133 HEPATITIS TOXIC 11 0.0042
134 DEVICE OPERATIONAL ISSUE 18 0.0042
135 VISUAL DISTURBANCE 24 0.0042
136 SUBCUTANEOUS ABSCESS 20 0.0042
137 HEMIPLEGIA 34 0.0041
138 GAIT DISTURBANCE 780 0.0041
139 MUSCLE TIGHTNESS 66 0.0041
140 DEPRESSED MOOD 215 0.0041
141 URINE ANALYSIS ABNORMAL 12 0.0040
142 ABSCESS LIMB 17 0.0040
143 FEELING COLD 111 0.0040
144 INJECTION SITE IRRITATION 50 0.0039
145 MONOPLEGIA 17 0.0039
146 INJECTION SITE PAIN 1198 0.0039
147 MUSCULAR WEAKNESS 440 0.0039
148 WHEELCHAIR USER 17 0.0038
149 INCONTINENCE 40 0.0038
150 TEMPERATURE INTOLERANCE 39 0.0038
151 BLINDNESS UNILATERAL 53 0.0038
152 INCOHERENT 24 0.0037
153 SCAR 63 0.0037
154 CLUMSINESS 10 0.0037
155 BONE MARROW DISORDER 11 0.0036
156 ABDOMINAL TENDERNESS 18 0.0036
157 DEPRESSION 815 0.0036
158 BLINDNESS TRANSIENT 26 0.0035
159 INJECTION SITE DISCOMFORT 37 0.0035
160 FIBULA FRACTURE 10 0.0035
161 VITAMIN B12 DECREASED 10 0.0035
162 HAEMANGIOMA 8 0.0035
163 HYPERREFLEXIA 12 0.0034
164 SKIN MASS 23 0.0034
165 SKIN WARM 20 0.0034
166 GOITRE 14 0.0034
167 HEPATIC ENZYME INCREASED 231 0.0034
168 DIPLOPIA 88 0.0034
169 ANTINUCLEAR ANTIBODY POSITIVE 11 0.0034
170 EYE MOVEMENT DISORDER 23 0.0034
171 HEPATOMEGALY 33 0.0034
172 GRAND MAL CONVULSION 31 0.0034
173 DYSGRAPHIA 22 0.0033
174 CYSTITIS 105 0.0033
175 LIPODYSTROPHY ACQUIRED 7 0.0033
176 PRODUCT DOSE OMISSION 214 0.0033
177 INTRACRANIAL ANEURYSM 13 0.0032
178 SENSORY LOSS 26 0.0032
179 LIVER FUNCTION TEST ABNORMAL 93 0.0032
180 LIMB MASS 7 0.0032
181 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 13 0.0032
182 LOSS OF CONTROL OF LEGS 12 0.0032
183 MICTURITION URGENCY 36 0.0031
184 MASS 44 0.0031
185 NECROTISING FASCIITIS 11 0.0031
186 FINE MOTOR SKILL DYSFUNCTION 9 0.0031
187 DRUG SPECIFIC ANTIBODY PRESENT 20 0.0031
188 INJECTION SITE INJURY 17 0.0031
189 ATAXIA 36 0.0030
190 CEREBRAL ATROPHY 12 0.0030
191 HYSTERECTOMY 26 0.0030
192 BLOOD POTASSIUM ABNORMAL 8 0.0030
193 OCULAR ICTERUS 13 0.0030
194 SARCOIDOSIS 14 0.0029
195 DYSAESTHESIA 9 0.0029
196 SKIN REACTION 41 0.0029
197 AUTOIMMUNE HEPATITIS 20 0.0029
198 JOINT LOCK 8 0.0028
199 ADVERSE DRUG REACTION 251 0.0028
200 MUSCULOSKELETAL DISORDER 53 0.0028
201 POSTURE ABNORMAL 9 0.0028
202 INTERVERTEBRAL DISC PROTRUSION 60 0.0027
203 CELLULITIS 138 0.0027
204 THYROID DISORDER 42 0.0027
205 DEAFNESS UNILATERAL 15 0.0027
206 MENOPAUSE 7 0.0027
207 ABDOMINAL ABSCESS 12 0.0027
208 ANKLE FRACTURE 42 0.0027
209 ARTHROPOD BITE 20 0.0027
210 HERNIA REPAIR 7 0.0027
211 INJECTION SITE SWELLING 206 0.0027
212 DRUG DOSE OMISSION 443 0.0027
213 BIPOLAR DISORDER 29 0.0027
214 ANOREXIA 34 0.0026
215 GASTRIC INFECTION 10 0.0026
216 COGNITIVE DISORDER 122 0.0026
217 INCREASED TENDENCY TO BRUISE 24 0.0026
218 INJECTION SITE DISCHARGE 14 0.0026
219 OVARIAN CYST 26 0.0026
220 LIMB DISCOMFORT 80 0.0026
221 FACIAL PAIN 23 0.0026
222 INTERVERTEBRAL DISC DISORDER 11 0.0026
223 MEMORY IMPAIRMENT 353 0.0026
224 SPEECH DISORDER 134 0.0026
225 CORONARY ARTERY OCCLUSION 35 0.0025
226 HEPATIC LESION 11 0.0025
227 HAEMORRHAGIC DIATHESIS 9 0.0025
228 FRUSTRATION 9 0.0025
229 INJECTION SITE VESICLES 15 0.0025
230 CARDIAC FLUTTER 16 0.0025
231 FALL 819 0.0025
232 PHARYNGOLARYNGEAL PAIN 13 0.0024
233 TREMOR 403 0.0024
234 HEPATIC STEATOSIS 45 0.0024
235 ADVERSE REACTION 32 0.0024
236 LYME DISEASE 8 0.0024
237 DYSSTASIA 70 0.0024
238 KIDNEY INFECTION 47 0.0024
239 ISCHAEMIA 11 0.0024
240 HEPATIC NECROSIS 9 0.0024
241 UROSEPSIS 22 0.0024
242 NERVE COMPRESSION 22 0.0024
243 INJECTION SITE WARMTH 49 0.0024
244 SENSORY DISTURBANCE 38 0.0024
245 INJECTION SITE NODULE 26 0.0024
246 MUSCLE FATIGUE 10 0.0024
247 CHOKING SENSATION 13 0.0024
248 YELLOW SKIN 11 0.0023
249 MUSCLE DISORDER 19 0.0023
250 URINARY TRACT INFECTION 399 0.0023
251 HEAD INJURY 74 0.0023
252 STAPHYLOCOCCAL INFECTION 77 0.0023
253 PERIPHERAL VASCULAR DISORDER 12 0.0023
254 BLOOD POTASSIUM DECREASED 70 0.0023
255 LOSS OF CONSCIOUSNESS 298 0.0023
256 MUSCULOSKELETAL STIFFNESS 203 0.0023
257 CARDIOMYOPATHY 34 0.0023
258 PREMATURE LABOUR 13 0.0023
259 BEDRIDDEN 30 0.0023
260 CHOLECYSTECTOMY 26 0.0023
261 DEPRESSIVE SYMPTOM 8 0.0023
262 MENINGITIS 15 0.0022
263 INJECTION SITE HYPERSENSITIVITY 7 0.0022
264 DYSARTHRIA 84 0.0022
265 BLADDER PAIN 7 0.0022
266 SCAB 25 0.0022
267 AFFECT LABILITY 21 0.0022
268 PYREXIA 748 0.0022
269 DRUG INTOLERANCE 208 0.0022
270 IMMUNODEFICIENCY 32 0.0021
271 RETINOPATHY 8 0.0021
272 LEUKAEMIA 20 0.0021
273 CONTUSION 203 0.0021
274 LUNG NEOPLASM 9 0.0021
275 FACE INJURY 8 0.0021
276 THERAPY CESSATION 108 0.0021
277 PARAESTHESIA 330 0.0021
278 TEARFULNESS 9 0.0021
279 BREAST MASS 14 0.0021
280 POST PROCEDURAL COMPLICATION 40 0.0021
281 NYSTAGMUS 11 0.0021
282 HEPATIC CYST 7 0.0021
283 IMMOBILE 9 0.0021
284 FOOT FRACTURE 39 0.0021
285 UTERINE LEIOMYOMA 15 0.0021
286 SKIN INFECTION 23 0.0020
287 BREAST CANCER FEMALE 54 0.0020
288 INJECTION SITE PRURITUS 135 0.0020
289 CHOLELITHIASIS 65 0.0020
290 GALLBLADDER OPERATION 8 0.0020
291 PERIPHERAL COLDNESS 27 0.0020
292 FEAR OF INJECTION 14 0.0020
293 MULTIPLE USE OF SINGLE-USE PRODUCT 11 0.0020
294 PROCEDURAL COMPLICATION 15 0.0020
295 MUSCLE SPASMS 359 0.0020
296 CHRONIC MYELOID LEUKAEMIA 9 0.0019
297 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
298 FACIAL BONES FRACTURE 7 0.0019
299 GENERALISED ERYTHEMA 11 0.0019
300 NIGHT SWEATS 62 0.0019
301 MIGRAINE 183 0.0019
302 SKIN ATROPHY 11 0.0019
303 GALLBLADDER DISORDER 34 0.0019
304 MENTAL IMPAIRMENT 46 0.0019
305 APHASIA 57 0.0019
306 AORTIC VALVE INCOMPETENCE 8 0.0019
307 FEELING HOT 114 0.0019
308 BURNING SENSATION 130 0.0019
309 AUTOIMMUNE THYROIDITIS 7 0.0018
310 HYPERSOMNIA 53 0.0018
311 VITAMIN D DEFICIENCY 18 0.0018
312 OVARIAN CANCER 17 0.0018
313 HYDROCEPHALUS 10 0.0018
314 PULMONARY THROMBOSIS 20 0.0018
315 DYSPHEMIA 8 0.0018
316 IMMUNOSUPPRESSION 16 0.0018
317 ASTHENIA 682 0.0018
318 LIGAMENT RUPTURE 8 0.0018
319 CONCUSSION 14 0.0018
320 FURUNCLE 14 0.0018
321 URINE ABNORMALITY 8 0.0018
322 COLD SWEAT 31 0.0018
323 PRURITUS GENERALISED 38 0.0018
324 ABSCESS 28 0.0018
325 AMNESIA 114 0.0018
326 LOCALISED INFECTION 42 0.0017
327 ASPIRATION 19 0.0017
328 GENERAL SYMPTOM 13 0.0017
329 VENTRICULAR EXTRASYSTOLES 18 0.0017
330 MENORRHAGIA 34 0.0017
331 ARTHRITIS INFECTIVE 8 0.0017
332 FORMICATION 12 0.0017
333 LOCAL SWELLING 30 0.0017
334 CAESAREAN SECTION 20 0.0017
335 INCORRECT DOSE ADMINISTERED BY DEVICE 45 0.0017
336 VISUAL ACUITY REDUCED 57 0.0017
337 URINARY RETENTION 57 0.0017
338 JOINT DISLOCATION 18 0.0017
339 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 14 0.0017
340 SPINAL COLUMN STENOSIS 8 0.0017
341 NEURALGIA 41 0.0017
342 REFUSAL OF TREATMENT BY PATIENT 11 0.0017
343 SKIN DISORDER 56 0.0017
344 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
345 PAIN IN EXTREMITY 494 0.0017
346 ACCIDENT 20 0.0017
347 MUSCLE RIGIDITY 20 0.0017
348 BODY TEMPERATURE INCREASED 34 0.0017
349 RASH PAPULAR 37 0.0016
350 LIVER DISORDER 73 0.0016
351 MAJOR DEPRESSION 12 0.0016
352 HYPERBILIRUBINAEMIA 17 0.0016
353 DISORIENTATION 65 0.0016
354 RENAL CYST 13 0.0016
355 RASH MACULAR 57 0.0016
356 CARDIAC OPERATION 14 0.0016
357 VISUAL IMPAIRMENT 201 0.0016
358 ABNORMAL LOSS OF WEIGHT 11 0.0016
359 COLON CANCER 24 0.0016
360 VEIN DISORDER 8 0.0016
361 JAUNDICE 43 0.0016
362 VERTIGO 97 0.0016
363 BLOOD COUNT ABNORMAL 24 0.0016
364 HYPERAESTHESIA 13 0.0016
365 HYPERTRANSAMINASAEMIA 11 0.0016
366 ACTIVITIES OF DAILY LIVING IMPAIRED 31 0.0016
367 INFLUENZA 174 0.0016
368 MENINGITIS ASEPTIC 7 0.0016
369 HYPERVENTILATION 9 0.0016
370 TRISMUS 8 0.0015
371 NEPHROLITHIASIS 71 0.0015
372 BLINDNESS 63 0.0015
373 PELVIC FRACTURE 12 0.0015
374 CRYING 56 0.0015
375 FATIGUE 1197 0.0015
376 ABDOMINAL HERNIA 7 0.0015
377 MULTIPLE ALLERGIES 12 0.0015
378 LYMPHOCYTE COUNT DECREASED 27 0.0015
379 KNEE OPERATION 15 0.0015
380 CATATONIA 8 0.0015
381 LIGAMENT SPRAIN 15 0.0015
382 FEELING OF DESPAIR 7 0.0015
383 DYSKINESIA 61 0.0015
384 HEARING IMPAIRED 9 0.0015
385 BLOOD DISORDER 12 0.0015
386 PHARYNGEAL OEDEMA 23 0.0015
387 OEDEMA PERIPHERAL 182 0.0015
388 FRUSTRATION TOLERANCE DECREASED 12 0.0015
389 SPINAL OSTEOARTHRITIS 13 0.0015
390 SLUGGISHNESS 15 0.0015
391 ENDOMETRIOSIS 7 0.0015
392 POLYURIA 12 0.0015
393 WOUND INFECTION 16 0.0015
394 CROHN'S DISEASE 10 0.0015
395 HYPERKERATOSIS 8 0.0014
396 MYOSITIS 13 0.0014
397 DIZZINESS POSTURAL 14 0.0014
398 GASTROENTERITIS VIRAL 26 0.0014
399 WHITE BLOOD CELL COUNT DECREASED 156 0.0014
400 WHITE BLOOD CELL COUNT INCREASED 55 0.0014
401 NECK PAIN 80 0.0014
402 RESTLESS LEGS SYNDROME 26 0.0014
403 BLEPHAROSPASM 9 0.0014
404 CARPAL TUNNEL SYNDROME 20 0.0014
405 MUSCLE ATROPHY 18 0.0014
406 MALIGNANT MELANOMA 19 0.0014
407 BRAIN NEOPLASM 13 0.0014
408 THYROID CANCER 17 0.0014
409 HAEMORRHAGIC STROKE 11 0.0014
410 JOINT INJURY 30 0.0014
411 VITAMIN D DECREASED 12 0.0014
412 MOVEMENT DISORDER 45 0.0014
413 UNEVALUABLE EVENT 106 0.0014
414 PREGNANCY 28 0.0014
415 HYPERTONIA 8 0.0014
416 HYPOAESTHESIA ORAL 21 0.0014
417 PARANOIA 24 0.0014
418 PAIN 855 0.0014
419 CORONARY ARTERIAL STENT INSERTION 7 0.0014
420 CYST 17 0.0014
421 POLLAKIURIA 57 0.0014
422 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
423 INJECTION SITE HAEMORRHAGE 109 0.0014
424 SECRETION DISCHARGE 17 0.0014
425 LOWER LIMB FRACTURE 26 0.0014
426 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
427 BLOOD IRON DECREASED 16 0.0013
428 HYPOTHYROIDISM 43 0.0013
429 HEADACHE 844 0.0013
430 BACK PAIN 312 0.0013
431 IMPAIRED HEALING 44 0.0013
432 PROTHROMBIN TIME PROLONGED 8 0.0013
433 THERAPEUTIC RESPONSE UNEXPECTED 60 0.0013
434 METASTASES TO LYMPH NODES 9 0.0013
435 CHEST PAIN 246 0.0013
436 GANGRENE 8 0.0013
437 VISION BLURRED 182 0.0013
438 RENAL PAIN 14 0.0013
439 BODY TEMPERATURE DECREASED 13 0.0013
440 IMPAIRED DRIVING ABILITY 15 0.0013
441 MATERNAL EXPOSURE BEFORE PREGNANCY 9 0.0013
442 EXOSTOSIS 12 0.0013
443 FLUSHING 133 0.0013
444 UPPER LIMB FRACTURE 26 0.0013
445 DROOLING 9 0.0013
446 ATRIOVENTRICULAR BLOCK 10 0.0013
447 MUSCULOSKELETAL CHEST PAIN 20 0.0013
448 SCOLIOSIS 8 0.0013
449 HERPES ZOSTER 74 0.0013
450 MIDDLE INSOMNIA 24 0.0013
451 APPENDICITIS 12 0.0013
452 HEART RATE IRREGULAR 29 0.0013
453 KNEE ARTHROPLASTY 27 0.0013
454 PRE-EXISTING CONDITION IMPROVED 8 0.0013
455 FEELING ABNORMAL 307 0.0013
456 SPLENOMEGALY 15 0.0013
457 MYOCARDIAL INFARCTION 223 0.0013
458 LACERATION 12 0.0013
459 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
460 MUSCLE STRAIN 11 0.0013
461 PHOTOPSIA 8 0.0013
462 DRUG EXPOSURE DURING PREGNANCY 43 0.0013
463 RETINAL HAEMORRHAGE 9 0.0013
464 BLOOD ALBUMIN DECREASED 10 0.0013
465 NERVE INJURY 14 0.0013
466 GAIT INABILITY 42 0.0013
467 INSOMNIA 333 0.0012
468 TENDERNESS 13 0.0012
469 PNEUMONIA ASPIRATION 31 0.0012
470 SKIN DISCOLOURATION 57 0.0012
471 STATUS EPILEPTICUS 14 0.0012
472 RASH GENERALISED 32 0.0012
473 THINKING ABNORMAL 23 0.0012
474 BLOOD SODIUM DECREASED 23 0.0012
475 RIB FRACTURE 25 0.0012
476 POOR QUALITY SLEEP 26 0.0012
477 THROMBOSIS 97 0.0012
478 SLEEP APNOEA SYNDROME 23 0.0012
479 HYPERHIDROSIS 155 0.0012
480 SKIN LESION 33 0.0012
481 LYMPHOPENIA 17 0.0012
482 RETINAL DETACHMENT 11 0.0012
483 RED BLOOD CELL COUNT DECREASED 34 0.0012
484 PAIN OF SKIN 32 0.0012
485 LYMPHADENOPATHY 42 0.0012
486 ULCER HAEMORRHAGE 8 0.0012
487 TOOTH FRACTURE 13 0.0012
488 CHOKING 23 0.0012
489 HYPERTHERMIA 9 0.0012
490 CARDIAC PACEMAKER INSERTION 7 0.0012
491 EATING DISORDER 25 0.0012
492 ROAD TRAFFIC ACCIDENT 49 0.0012
493 HYPOKINESIA 17 0.0012
494 EYE PAIN 66 0.0012
495 INITIAL INSOMNIA 12 0.0012
496 SUICIDAL IDEATION 107 0.0012
497 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
498 BLOOD URINE PRESENT 22 0.0012
499 EYE DISORDER 38 0.0012
500 MUSCULOSKELETAL PAIN 60 0.0011
501 SCRATCH 12 0.0011
502 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
503 OBESITY 18 0.0011
504 INJURY ASSOCIATED WITH DEVICE 23 0.0011
505 VAGINAL HAEMORRHAGE 49 0.0011
506 MUSCLE TWITCHING 26 0.0011
507 RESPIRATORY ARREST 31 0.0011
508 SKIN ULCER 29 0.0011
509 SWOLLEN TONGUE 35 0.0011
510 JOINT RANGE OF MOTION DECREASED 15 0.0011
511 PSYCHOTIC DISORDER 33 0.0011
512 DYSPHAGIA 106 0.0011
513 RHINITIS 9 0.0011
514 ANAL INCONTINENCE 10 0.0011
515 MYALGIA 189 0.0011
516 HEART RATE DECREASED 39 0.0011
517 PHARYNGITIS STREPTOCOCCAL 12 0.0011
518 VISUAL FIELD DEFECT 8 0.0011
519 TONGUE DISORDER 8 0.0011
520 HYPERTHYROIDISM 16 0.0011
521 LUPUS-LIKE SYNDROME 10 0.0011
522 HYPOTONIA 11 0.0011
523 DIZZINESS 548 0.0011
524 APATHY 16 0.0011
525 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
526 WRIST FRACTURE 13 0.0011
527 EYELID PTOSIS 11 0.0011
528 MEDICAL DEVICE COMPLICATION 8 0.0011
529 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
530 ANGINA UNSTABLE 7 0.0011
531 SEIZURE 124 0.0011
532 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
533 MALNUTRITION 12 0.0011
534 BLOOD PRESSURE DECREASED 71 0.0011
535 LIMB INJURY 29 0.0011
536 DEHYDRATION 142 0.0011
537 ANGER 36 0.0011
538 MALAISE 466 0.0011
539 IMMUNE SYSTEM DISORDER 14 0.0011
540 HAEMATOCRIT DECREASED 21 0.0011
541 CARDIAC FAILURE CONGESTIVE 85 0.0011
542 PRODUCT AVAILABILITY ISSUE 24 0.0011
543 CEREBROVASCULAR ACCIDENT 178 0.0010
544 OSTEOMYELITIS 19 0.0010
545 ANGINA PECTORIS 30 0.0010
546 WEIGHT DECREASED 290 0.0010
547 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
548 LUNG INFECTION 16 0.0010
549 JOINT STIFFNESS 27 0.0010
550 EAR PAIN 20 0.0010
551 HYPERSENSITIVITY 190 0.0010
552 HEAD DISCOMFORT 18 0.0010
553 LYMPHOEDEMA 7 0.0010
554 SKIN LACERATION 11 0.0010
555 MENTAL STATUS CHANGES 28 0.0010
556 LARGE INTESTINE PERFORATION 7 0.0010
557 EXTRASYSTOLES 7 0.0010
558 HEART RATE INCREASED 99 0.0010
559 LUNG NEOPLASM MALIGNANT 41 0.0010
560 HIP FRACTURE 32 0.0010
561 TOOTHACHE 18 0.0010
562 ALANINE AMINOTRANSFERASE INCREASED 61 0.0010
563 CORONARY ARTERY DISEASE 30 0.0010
564 MYASTHENIA GRAVIS 8 0.0010
565 NOCTURIA 12 0.0010
566 HAND FRACTURE 7 0.0010
567 CHEST DISCOMFORT 101 0.0010
568 NERVOUSNESS 51 0.0010
569 IRON DEFICIENCY ANAEMIA 9 0.0010
570 CHROMATURIA 22 0.0010
571 EAR DISCOMFORT 10 0.0010
572 ESCHERICHIA INFECTION 8 0.0010
573 GENERALISED OEDEMA 12 0.0010
574 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
575 MENSTRUAL DISORDER 8 0.0010
576 DIARRHOEA HAEMORRHAGIC 9 0.0010
577 GASTRIC DISORDER 33 0.0010
578 PANIC ATTACK 35 0.0010
579 ABNORMAL BEHAVIOUR 38 0.0010
580 BLOOD PRESSURE FLUCTUATION 23 0.0010
581 SYSTEMIC LUPUS ERYTHEMATOSUS 34 0.0010
582 NEOPLASM 11 0.0010
583 HALLUCINATION 72 0.0010
584 DERMATITIS ALLERGIC 12 0.0010
585 SKIN PLAQUE 8 0.0009
586 DISTURBANCE IN ATTENTION 51 0.0009
587 FULL BLOOD COUNT ABNORMAL 10 0.0009
588 ULCER 15 0.0009
589 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
590 SPINAL PAIN 11 0.0009
591 WOUND 26 0.0009
592 INFLAMMATION 48 0.0009
593 NERVOUS SYSTEM DISORDER 29 0.0009
594 THROAT TIGHTNESS 25 0.0009
595 PALPITATIONS 108 0.0009
596 HYPERLIPIDAEMIA 11 0.0009
597 CARDIAC DISORDER 86 0.0009
598 HOT FLUSH 69 0.0009
599 SINUS TACHYCARDIA 13 0.0009
600 GASTRITIS 24 0.0009
601 HEPATITIS C 11 0.0009
602 METASTASES TO LIVER 16 0.0009
603 CONFUSIONAL STATE 147 0.0009
604 URTICARIA 152 0.0009
605 HEPATIC CIRRHOSIS 17 0.0009
606 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
607 ADVERSE EVENT 83 0.0009
608 EYE HAEMORRHAGE 12 0.0009
609 COLITIS 34 0.0009
610 MENTAL DISORDER 39 0.0009
611 NASOPHARYNGITIS 165 0.0009
612 GASTRIC ULCER 17 0.0009
613 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
614 AFFECTIVE DISORDER 7 0.0009
615 BLOOD CALCIUM DECREASED 10 0.0009
616 TOOTH ABSCESS 9 0.0009
617 MITRAL VALVE INCOMPETENCE 10 0.0009
618 COMA 42 0.0009
619 HALLUCINATION, AUDITORY 14 0.0009
620 MOOD ALTERED 24 0.0009
621 SYNCOPE 88 0.0009
622 OSTEOPOROSIS 36 0.0009
623 VIRAL INFECTION 29 0.0009
624 BRAIN OEDEMA 11 0.0009
625 HYPERTENSION 184 0.0009
626 BLOOD PRESSURE INCREASED 132 0.0009
627 BACK DISORDER 14 0.0009
628 RENAL DISORDER 40 0.0009
629 VASCULITIS 10 0.0009
630 BACTERIAL INFECTION 16 0.0009
631 DEVICE USE ISSUE 15 0.0009
632 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
633 ROTATOR CUFF SYNDROME 11 0.0009
634 FEAR 23 0.0009
635 FLANK PAIN 8 0.0009
636 HICCUPS 7 0.0009
637 ARTERIOSCLEROSIS 8 0.0008
638 ANXIETY 241 0.0008
639 DEATH 728 0.0008
640 SWELLING FACE 55 0.0008
641 BREAST PAIN 9 0.0008
642 PROTEINURIA 16 0.0008
643 ALOPECIA 165 0.0008
644 FEELING JITTERY 16 0.0008
645 IRRITABLE BOWEL SYNDROME 18 0.0008
646 CHOLECYSTITIS 10 0.0008
647 DELUSION 13 0.0008
648 ERYTHEMA 171 0.0008
649 BACK INJURY 9 0.0008
650 HAEMORRHOIDS 16 0.0008
651 ORAL HERPES 16 0.0008
652 MOOD SWINGS 26 0.0008
653 SCIATICA 13 0.0008
654 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
655 BLOOD CHOLESTEROL INCREASED 38 0.0008
656 DYSURIA 30 0.0008
657 LIVER INJURY 20 0.0008
658 VITREOUS FLOATERS 8 0.0008
659 MUSCULOSKELETAL DISCOMFORT 14 0.0008
660 CARDIOMEGALY 10 0.0008
661 CONDITION AGGRAVATED 247 0.0008
662 UVEITIS 11 0.0008
663 LIP SWELLING 27 0.0008
664 VOMITING 381 0.0008
665 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
666 SINUS DISORDER 16 0.0008
667 RESPIRATORY TRACT INFECTION 21 0.0008
668 ACUTE HEPATIC FAILURE 11 0.0008
669 ILEUS 10 0.0008
670 SINUSITIS 82 0.0008
671 LEUKOPENIA 40 0.0008
672 BLOOD CALCIUM INCREASED 7 0.0008
673 PHOTOPHOBIA 15 0.0008
674 RETCHING 17 0.0008
675 GROIN PAIN 7 0.0008
676 RESPIRATORY FAILURE 58 0.0008
677 LIVER FUNCTION TEST INCREASED 17 0.0008
678 HAEMATEMESIS 20 0.0008
679 SUBARACHNOID HAEMORRHAGE 8 0.0008
680 BLOOD TEST ABNORMAL 11 0.0008
681 GASTROINTESTINAL INFECTION 7 0.0008
682 EJECTION FRACTION DECREASED 12 0.0008
683 HAEMATOMA 20 0.0008
684 PALLOR 21 0.0008
685 SEPSIS 86 0.0008
686 HOSPITALISATION 118 0.0008
687 TREATMENT FAILURE 63 0.0008
688 TOOTH INFECTION 10 0.0008
689 PULMONARY CONGESTION 10 0.0008
690 HALLUCINATION, VISUAL 16 0.0008
691 PNEUMOTHORAX 12 0.0008
692 BONE PAIN 44 0.0008
693 DIABETES MELLITUS 57 0.0007
694 BREAST CANCER METASTATIC 8 0.0007
695 NAUSEA 588 0.0007
696 HEPATITIS 19 0.0007
697 BLOOD POTASSIUM INCREASED 12 0.0007
698 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
699 ABDOMINAL DISTENSION 77 0.0007
700 UNRESPONSIVE TO STIMULI 19 0.0007
701 DRUG INEFFECTIVE 970 0.0007
702 SPINAL OPERATION 9 0.0007
703 INJECTION SITE EXTRAVASATION 9 0.0007
704 ANAEMIA 139 0.0007
705 CEREBRAL HAEMORRHAGE 26 0.0007
706 ABORTION SPONTANEOUS 29 0.0007
707 HEPATIC FUNCTION ABNORMAL 27 0.0007
708 DENTAL CARIES 8 0.0007
709 PNEUMONIA 234 0.0007
710 FOOT DEFORMITY 8 0.0007
711 HIP ARTHROPLASTY 11 0.0007
712 SURGERY 42 0.0007
713 COELIAC DISEASE 7 0.0007
714 ABDOMINAL PAIN 166 0.0007
715 ARTHRALGIA 296 0.0007
716 LYMPHOMA 11 0.0007
717 LABORATORY TEST ABNORMAL 21 0.0007
718 TENDONITIS 11 0.0007
719 MATERNAL EXPOSURE DURING PREGNANCY 63 0.0007
720 INFECTION 102 0.0007
721 BLOOD PRESSURE ABNORMAL 14 0.0007
722 BLOOD GLUCOSE ABNORMAL 13 0.0007
723 CONJUNCTIVITIS 13 0.0007
724 CYANOSIS 11 0.0007
725 SUBDURAL HAEMATOMA 10 0.0007
726 BREAST CANCER 65 0.0007
727 GASTRIC HAEMORRHAGE 8 0.0007
728 HIATUS HERNIA 9 0.0007
729 PARAESTHESIA ORAL 10 0.0007
730 PANCREATIC CARCINOMA 20 0.0007
731 METASTASES TO LUNG 8 0.0007
732 PERICARDIAL EFFUSION 16 0.0007
733 DELIRIUM 24 0.0007
734 CATARACT 41 0.0007
735 DIVERTICULITIS 19 0.0007
736 ORAL CANDIDIASIS 9 0.0007
737 CONSTIPATION 149 0.0007
738 SLEEP DISORDER 48 0.0007
739 LETHARGY 39 0.0007
740 SWELLING 63 0.0007
741 THIRST 12 0.0007
742 MYOCLONUS 8 0.0007
743 GASTROINTESTINAL DISORDER 60 0.0007
744 CARDIOVASCULAR DISORDER 17 0.0007
745 VENTRICULAR TACHYCARDIA 11 0.0007
746 ABDOMINAL PAIN UPPER 137 0.0007
747 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
748 NASAL CONGESTION 39 0.0007
749 HEPATIC FAILURE 20 0.0007
750 DYSPNOEA 374 0.0007
751 DISABILITY 13 0.0007
752 EPILEPSY 20 0.0007
753 HAEMATOCHEZIA 36 0.0007
754 FACE OEDEMA 11 0.0007
755 ENCEPHALOPATHY 16 0.0007
756 PROCEDURAL PAIN 18 0.0006
757 SPINAL FRACTURE 13 0.0006
758 ARTHRITIS 51 0.0006
759 APHONIA 9 0.0006
760 PULMONARY EMBOLISM 61 0.0006
761 EPISTAXIS 48 0.0006
762 BASAL CELL CARCINOMA 10 0.0006
763 AGGRESSION 32 0.0006
764 SEASONAL ALLERGY 9 0.0006
765 PAIN IN JAW 18 0.0006
766 BRONCHITIS 47 0.0006
767 RHINORRHOEA 41 0.0006
768 ABDOMINAL PAIN LOWER 16 0.0006
769 RESPIRATORY TRACT CONGESTION 10 0.0006
770 RECTAL HAEMORRHAGE 27 0.0006
771 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
772 PULMONARY FIBROSIS 12 0.0006
773 INTESTINAL PERFORATION 7 0.0006
774 GASTROOESOPHAGEAL REFLUX DISEASE 50 0.0006
775 EYE INFECTION 7 0.0006
776 EYE SWELLING 23 0.0006
777 EMOTIONAL DISORDER 19 0.0006
778 SOMNOLENCE 123 0.0006
779 INTESTINAL OBSTRUCTION 23 0.0006
780 DYSPEPSIA 60 0.0006
781 SKIN HAEMORRHAGE 9 0.0006
782 CARDIAC ARREST 50 0.0006
783 DEEP VEIN THROMBOSIS 39 0.0006
784 IRRITABILITY 36 0.0006
785 ATRIAL FIBRILLATION 58 0.0006
786 OSTEOPENIA 9 0.0006
787 LUNG DISORDER 29 0.0006
788 FEEDING DISORDER 12 0.0006
789 ARRHYTHMIA 28 0.0006
790 HYPOPHAGIA 15 0.0006
791 PANCREATITIS 31 0.0006
792 GINGIVAL BLEEDING 8 0.0006
793 WEIGHT INCREASED 131 0.0006
794 TRANSAMINASES INCREASED 13 0.0006
795 MULTI-ORGAN FAILURE 10 0.0006
796 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
797 PULMONARY HYPERTENSION 12 0.0006
798 FIBROMYALGIA 14 0.0006
799 DISCOMFORT 35 0.0006
800 DERMATITIS 12 0.0006
801 DEMENTIA 16 0.0006
802 ANHEDONIA 15 0.0006
803 AMENORRHOEA 10 0.0006
804 BLISTER 32 0.0006
805 DRY MOUTH 46 0.0006
806 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
807 RASH ERYTHEMATOUS 27 0.0006
808 TACHYCARDIA 50 0.0006
809 IMPAIRED WORK ABILITY 12 0.0006
810 SUICIDE ATTEMPT 34 0.0006
811 DRUG EFFECT DECREASED 30 0.0006
812 BLOOD BILIRUBIN INCREASED 15 0.0006
813 LEUKOCYTOSIS 10 0.0006
814 PRESCRIBED UNDERDOSE 11 0.0006
815 ACUTE MYOCARDIAL INFARCTION 16 0.0005
816 OSTEOARTHRITIS 23 0.0005
817 DRUG-INDUCED LIVER INJURY 17 0.0005
818 DRY EYE 27 0.0005
819 OROPHARYNGEAL PAIN 50 0.0005
820 FUNGAL INFECTION 18 0.0005
821 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
822 PRODUCT USE ISSUE 100 0.0005
823 PREMATURE BABY 16 0.0005
824 DYSMENORRHOEA 7 0.0005
825 RENAL FAILURE 70 0.0005
826 DEVICE MALFUNCTION 37 0.0005
827 NEUROPATHY PERIPHERAL 50 0.0005
828 ABDOMINAL DISCOMFORT 88 0.0005
829 ACUTE RESPIRATORY FAILURE 10 0.0005
830 RENAL FAILURE ACUTE 22 0.0005
831 ORTHOSTATIC HYPOTENSION 9 0.0005
832 PLATELET COUNT DECREASED 55 0.0005
833 DIARRHOEA 333 0.0005
834 SYRINGE ISSUE 9 0.0005
835 IMPAIRED GASTRIC EMPTYING 7 0.0005
836 DYSPHONIA 30 0.0005
837 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
838 TREATMENT NONCOMPLIANCE 28 0.0005
839 FAECES DISCOLOURED 11 0.0005
840 RESPIRATORY DISTRESS 14 0.0005
841 SEPTIC SHOCK 22 0.0005
842 HUNGER 7 0.0005
843 HAEMOGLOBIN DECREASED 51 0.0005
844 ASTHMA 56 0.0005
845 PELVIC PAIN 9 0.0005
846 GENERAL PHYSICAL HEALTH DETERIORATION 57 0.0005
847 RESTLESSNESS 18 0.0005
848 ORAL PAIN 11 0.0005
849 PERIPHERAL SWELLING 75 0.0005
850 RASH 212 0.0005
851 INJURY 34 0.0005
852 COAGULOPATHY 8 0.0005
853 TINNITUS 22 0.0005
854 PRURITUS 184 0.0005
855 BLOOD UREA INCREASED 8 0.0005
856 DECREASED APPETITE 110 0.0005
857 CIRCULATORY COLLAPSE 8 0.0005
858 ARTHROPATHY 26 0.0005
859 HERNIA 9 0.0005
860 NEOPLASM MALIGNANT 31 0.0005
861 RASH PRURITIC 25 0.0005
862 DEVICE FAILURE 7 0.0005
863 DEAFNESS 12 0.0005
864 OSTEONECROSIS 15 0.0005
865 JOINT SWELLING 55 0.0005
866 DEVICE RELATED INFECTION 7 0.0005
867 FLUID RETENTION 23 0.0005
868 DRUG ERUPTION 8 0.0005
869 DYSPNOEA EXERTIONAL 17 0.0005
870 EAR INFECTION 12 0.0005
871 MEDICATION ERROR 25 0.0004
872 HAEMORRHAGE 47 0.0004
873 HEPATOTOXICITY 10 0.0004
874 PRODUCT DOSE OMISSION ISSUE 132 0.0004
875 MENSTRUATION IRREGULAR 12 0.0004
876 PULMONARY OEDEMA 20 0.0004
877 NEEDLE ISSUE 13 0.0004
878 SNEEZING 10 0.0004
879 OEDEMA 24 0.0004
880 BONE DISORDER 8 0.0004
881 HYPOTENSION 88 0.0004
882 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
883 COUGH 122 0.0004
884 RESPIRATORY DISORDER 13 0.0004
885 INTENTIONAL PRODUCT MISUSE 38 0.0004
886 CARDIO-RESPIRATORY ARREST 18 0.0004
887 METASTASES TO BONE 7 0.0004
888 MANIA 7 0.0004
889 CARDIAC FAILURE 34 0.0004
890 BLOOD GLUCOSE INCREASED 79 0.0004
891 PRODUCTIVE COUGH 20 0.0004
892 BLOOD GLUCOSE DECREASED 20 0.0004
893 GLAUCOMA 8 0.0004
894 DRUG EFFECT INCOMPLETE 15 0.0004
895 HAEMATURIA 14 0.0004
896 DISEASE PROGRESSION 48 0.0004
897 THERAPY NON-RESPONDER 18 0.0004
898 HYPOXIA 14 0.0004
899 FULL BLOOD COUNT DECREASED 8 0.0004
900 EXTRA DOSE ADMINISTERED 16 0.0004
901 HYPOACUSIS 17 0.0004
902 HAEMOPTYSIS 11 0.0004
903 SHOCK 9 0.0004
904 HYPOKALAEMIA 18 0.0004
905 FEMUR FRACTURE 12 0.0004
906 TYPE 2 DIABETES MELLITUS 13 0.0004
907 INTENTIONAL DRUG MISUSE 8 0.0004
908 NIGHTMARE 13 0.0004
909 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 67 0.0004
910 PRESYNCOPE 9 0.0004
911 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
912 ERUCTATION 7 0.0004
913 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
914 STEVENS-JOHNSON SYNDROME 8 0.0004
915 THROAT IRRITATION 16 0.0004
916 ERECTILE DYSFUNCTION 9 0.0004
917 SKIN IRRITATION 16 0.0003
918 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
919 ANAPHYLACTIC REACTION 19 0.0003
920 APPLICATION SITE ERYTHEMA 9 0.0003
921 EXPIRED PRODUCT ADMINISTERED 11 0.0003
922 ABNORMAL DREAMS 9 0.0003
923 SKIN EXFOLIATION 27 0.0003
924 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
925 ANGIOEDEMA 14 0.0003
926 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
927 NO ADVERSE EVENT 57 0.0003
928 GLOSSODYNIA 7 0.0003
929 PLEURAL EFFUSION 19 0.0003
930 ANAPHYLACTIC SHOCK 8 0.0003
931 DYSGEUSIA 23 0.0003
932 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
933 OXYGEN SATURATION DECREASED 17 0.0003
934 AGITATION 22 0.0003
935 COVID-19 51 0.0003
936 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
937 WHEEZING 17 0.0003
938 CEREBRAL INFARCTION 7 0.0003
939 PANCYTOPENIA 16 0.0003
940 AGEUSIA 7 0.0003
941 ILL-DEFINED DISORDER 17 0.0003
942 RENAL IMPAIRMENT 23 0.0003
943 THERAPEUTIC RESPONSE DECREASED 16 0.0003
944 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
945 DRY SKIN 33 0.0002
946 UNDERDOSE 18 0.0002
947 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
948 DRUG INTERACTION 39 0.0002
949 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
950 DRUG DOSE OMISSION BY DEVICE 19 0.0002
951 EXPOSURE DURING PREGNANCY 15 0.0002
952 INCORRECT DOSE ADMINISTERED 55 0.0002
953 ILLNESS 24 0.0002
954 FLATULENCE 13 0.0002
955 DRUG ADMINISTRATION ERROR 7 0.0002
956 ACNE 17 0.0002
957 DEVICE BREAKAGE 9 0.0002
958 WITHDRAWAL SYNDROME 9 0.0002
959 OCULAR HYPERAEMIA 10 0.0002
960 DISEASE RECURRENCE 10 0.0002
961 THROMBOCYTOPENIA 23 0.0002
962 BLADDER CANCER 12 0.0002
963 RHEUMATOID ARTHRITIS 23 0.0002
964 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
965 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
966 STOMATITIS 12 0.0002
967 NEUTROPHIL COUNT DECREASED 8 0.0002
968 SKIN BURNING SENSATION 14 0.0002
969 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
970 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
971 BRADYCARDIA 10 0.0002
972 PROSTATE CANCER 15 0.0002
973 COLITIS ULCERATIVE 8 0.0002
974 PSORIASIS 23 0.0002
975 RENAL CANCER 8 0.0002
976 HYPOGLYCAEMIA 8 0.0002
977 OFF LABEL USE 139 0.0002
978 EYE IRRITATION 9 0.0002
979 DEVICE ISSUE 14 0.0002
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
981 EMOTIONAL DISTRESS 18 0.0001
982 DRUG WITHDRAWAL SYNDROME 12 0.0001
983 DEVICE DIFFICULT TO USE 9 0.0001
984 ECZEMA 7 0.0001
985 BLOOD CREATININE INCREASED 8 0.0001
986 INFUSION RELATED REACTION 8 0.0001
987 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
988 THERAPY INTERRUPTED 8 0.0001
989 FEBRILE NEUTROPENIA 7 0.0001
990 NEUTROPENIA 14 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
992 COMPLETED SUICIDE 8 0.0001
993 PRODUCT QUALITY ISSUE 13 0.0001
994 OVERDOSE 18 0.0001
995 ACUTE KIDNEY INJURY 10 0.0001
996 TOXICITY TO VARIOUS AGENTS 11 0.0001